COPD is diagnosed through a combination of symptom evaluation, risk factor assessment, and a breathing test called spirometry. The key diagnostic threshold is a specific ratio measured during spirometry: if the amount of air you can force out in one second divided by your total forced exhale volume falls below 0.7, that confirms the airflow obstruction characteristic of COPD.
The process typically starts in a doctor’s office after you report persistent breathing problems, but spirometry is what separates a clinical suspicion from a confirmed diagnosis. Here’s what each step involves and what to expect.
Symptoms and Risk Factors Come First
Before any testing, your doctor will ask about your breathing and your history. The symptoms that raise suspicion for COPD include chronic cough (with or without mucus), shortness of breath that’s gotten worse over time, wheezing, and chest tightness. These symptoms alone don’t confirm COPD, but they’re what triggers the diagnostic workup.
Equally important is your exposure history. Smoking is the most common risk factor, but long-term exposure to dust, chemical fumes, or indoor air pollution from cooking fuels also qualifies. COPD generally shows up from middle adulthood onward, and the risk increases with age. If you’re younger than 40 with no exposure history, your doctor will likely consider other explanations first.
What Happens During a Physical Exam
A physical exam can reveal signs of COPD, though these tend to appear in more advanced disease rather than early stages. Your doctor will listen to your lungs with a stethoscope and tap on your chest. Diminished breath sounds are one of the best physical indicators of chronic airflow obstruction. A scoring system that grades breath sound intensity across six locations on the chest can strongly increase or decrease the likelihood of COPD depending on how quiet or loud your breathing sounds are.
Tapping on the chest (percussion) can also be telling. A hollow, hyperresonant sound is the strongest physical predictor of COPD, with very high specificity, meaning it rarely shows up in people who don’t have the disease. In advanced emphysema, the chest may take on a barrel shape, where the front-to-back diameter expands to match the side-to-side diameter. Other visible signs include a prominent breastbone, elevated collarbones, and widened spaces between the ribs. None of these physical findings alone can confirm COPD, but they help build the clinical picture.
Spirometry: The Test That Confirms COPD
Spirometry is the essential test. You breathe into a mouthpiece connected to a machine, inhale as deeply as you can, then blow out as hard and as long as possible. The machine measures two key values: how much air you can force out in the first second (FEV1) and the total volume of air you can exhale (FVC). The ratio between these two numbers is what matters most.
An FEV1/FVC ratio below 0.7 confirms airflow obstruction consistent with COPD. The Global Initiative for Chronic Obstructive Lung Disease (GOLD), the leading international authority on COPD management, uses this fixed ratio as the diagnostic cutoff and recommends it over age-adjusted alternatives.
Pre- and Post-Bronchodilator Testing
Spirometry is often performed before and after you inhale a fast-acting bronchodilator, a medication that relaxes and opens the airways. You’ll typically wait about 15 to 20 minutes after inhaling the medication before repeating the breathing test. If your ratio is above 0.7 before the bronchodilator, COPD can generally be ruled out. If it’s below 0.7 before the bronchodilator, the post-bronchodilator measurement is needed to confirm the diagnosis.
Some people see their ratio improve to above 0.7 after the bronchodilator. These individuals still have a high likelihood of developing COPD over time and need ongoing monitoring. If you’re taking any inhaled medications before the test, you’ll be asked to stop them in advance: short-acting inhalers for 6 to 8 hours beforehand and long-acting inhalers for at least 12 hours.
Telling COPD Apart From Asthma
One of the trickiest parts of diagnosis is distinguishing COPD from asthma, since both cause shortness of breath and wheezing. Several features help separate them. Asthma often begins in childhood and is linked to allergies, while COPD typically appears in middle age or later and is tied to smoking or occupational exposures. Asthma symptoms tend to fluctuate, sometimes disappearing entirely between flare-ups, while COPD symptoms are persistent and progressive.
Bronchodilator response also plays a role. In asthma, FEV1 or FVC typically improves by more than 12% or at least 200 milliliters after a bronchodilator. COPD patients generally show less reversibility. But this distinction isn’t clean-cut: some COPD patients do show significant bronchodilator response, and some people with long-standing asthma lose their reversibility over time. When the picture is unclear, your doctor may use additional testing, symptom patterns, and your history to reach the right diagnosis.
Assessing Symptom Severity
Once COPD is suspected or confirmed, your doctor will formally assess how much your breathing affects daily life. The most widely used tool is the mMRC breathlessness scale, which grades shortness of breath from 0 to 4:
- Grade 0: Breathless only during strenuous exercise
- Grade 1: Short of breath when hurrying or walking up a slight hill
- Grade 2: Walking slower than people your age on flat ground, or needing to stop for breath at your own pace
- Grade 3: Stopping for breath after about 100 meters or a few minutes of walking on flat ground
- Grade 4: Too breathless to leave the house, or breathless while dressing
This score, along with your spirometry results and history of flare-ups, helps determine how aggressively your COPD needs to be managed.
When CT Scans and Other Imaging Are Used
A chest X-ray or CT scan is not required to diagnose COPD, and GOLD guidelines do not recommend routine CT scanning. However, imaging becomes useful in specific situations: ruling out other conditions that mimic COPD (like lung cancer or heart failure), identifying the structural damage emphysema causes, or evaluating whether someone with severe disease might benefit from surgical options.
CT scans can reveal three key features of COPD that spirometry cannot: emphysema (destruction of the tiny air sacs), thickening of the airway walls, and gas trapping, where air gets stuck in the lungs because damaged airways collapse during exhalation. CT can also identify large air-filled spaces called bullae that may be candidates for surgical removal. For people with severe COPD being considered for lung volume reduction procedures, CT imaging is considered essential.
Blood Tests and Genetic Screening
A standard blood test called a complete blood count may be done to check for other conditions, but the most important blood test in COPD diagnosis is screening for alpha-1 antitrypsin deficiency. This is a genetic condition where the body doesn’t produce enough of a protein that protects the lungs from damage. People with this deficiency can develop COPD even without smoking, and they often develop it at a younger age.
Both the American Thoracic Society and the European Respiratory Society recommend testing all COPD patients for this deficiency, regardless of age, ethnicity, symptom severity, or smoking history. Despite these guidelines, testing rates remain low. Doctors sometimes assume that older patients or heavy smokers don’t need screening, but the deficiency can be present alongside smoking-related damage, and identifying it changes treatment options.
Gas Transfer Testing for Emphysema
Beyond spirometry, a specialized breathing test measures how well your lungs transfer gas from inhaled air into your bloodstream. You breathe in a small, harmless amount of a tracer gas, hold your breath briefly, then exhale. The amount of gas your lungs absorb reveals how well the air sacs are functioning.
This test is one of the best ways to detect and gauge the severity of emphysema, because destroyed air sacs can’t transfer gas efficiently even when spirometry numbers haven’t dropped dramatically. When gas transfer falls to 50% or below what’s predicted for your age and size, it signals severe impairment and is associated with reduced exercise capacity and more frequent flare-ups. Current thinking in COPD care recognizes that spirometry alone doesn’t fully predict symptoms, quality of life, or how often flare-ups will occur, making gas transfer testing increasingly valuable for building a complete picture of someone’s disease.